Open AccessEmerging treatment options for cryptosporidiosis
Author(s) -
Melissa S. Love,
Robert K. M. Choy
Publication year - 2021
Publication title -
current opinion in infectious diseases/current opinion in infectious diseases, with evaluated medline
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.68
H-Index - 103
eISSN - 1080-7861
pISSN - 0951-7375
DOI - 10.1097/qco.0000000000000761
Subject(s) - medicine , cryptosporidium , clinical trial , drug discovery , antimycobacterial , pharmacology , bioinformatics , biology , tuberculosis , microbiology and biotechnology , mycobacterium tuberculosis , pathology , feces
Substantial progress has been made recently on the development of new therapeutics for cryptosporidiosis, an infection by the protozoan parasite Cryptosporidium that is associated with diarrhea, malnutrition, growth stunting, cognitive deficits, and oral vaccine failure in children living in low-resource settings.